دورية أكاديمية

IL-21 augments rapamycin in expansion of alpha fetoprotein antigen specific stem-cell-like memory T cells in vitro

التفاصيل البيبلوغرافية
العنوان: IL-21 augments rapamycin in expansion of alpha fetoprotein antigen specific stem-cell-like memory T cells in vitro
المؤلفون: Victor Tunje Jeza, Xiaoyi Li, Jun Chen, Zhihui Liang, Aggrey Onago Adem, Xiongwen Wu
المصدر: The Pan African Medical Journal, Vol 27, Iss 163 (2017)
بيانات النشر: The Pan African Medical Journal, 2017.
سنة النشر: 2017
المجموعة: LCC:Medicine
مصطلحات موضوعية: alpha fetoprotein, tscm cells, il-21, rapamycin, concurrent application, cancer immunotherapies, Medicine
الوصف: INTRODUCTION: Alloreactive tumor specific T cells are important arsenals of the adaptive immune system in the fight against tumors. However, stem cell-like memory T cells (Tscm) provide the key to effective elimination of tumor cells. Methods for generating these T cell subsets already exist. However, they could be made more efficient. Further, they are expensive and unattainable to the resource poor laboratories. In this regard, we are hereby describing a novel in vitro allogeneic co-culture method for raising allo-restricted tumor specific Tscm cells that we developed. METHODS: we started by obtaining PBLs that screened negative for HLA-A2 molecules from healthy donors followed by co-culture with T2/AFP cells to generate AFP peptide specific tumor-reactive T cells. Controls, IL-21 and/or rapamycin were applied to samples in 24 well plates. Samples were harvested and stained with anti-human CD3, CD8, CD44, CD62L, and HLA-A2/AFP dimer followed by flow cytometry analysis. Cell viability was measured by Trypan blue exclusion assay. One Way ANOVA and independent t test were used to compare the mean differences among and between groups where P values less than 0.05 were considered significant. RESULTS: our results show that rapamycin arrests the differentiation of, and expands AFP specific Tscm cells. Further, the expansion of Tscm cells is augmented in the presence of IL-21. CONCLUSION: IL-21 and Rapamycin can be used concurrently to raise and maintain antigen specific Tscm cells in vitro for purposes of augmenting immunotherapy strategies against cancers.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
French
تدمد: 1937-8688
العلاقة: https://www.panafrican-med-journal.com/content/article/27/163/pdf/163.pdfTest; https://doaj.org/toc/1937-8688Test
DOI: 10.11604/pamj.2017.27.163.11072
الوصول الحر: https://doaj.org/article/7d507b5df26443ce9e13f141c46696cdTest
رقم الانضمام: edsdoj.7d507b5df26443ce9e13f141c46696cd
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:19378688
DOI:10.11604/pamj.2017.27.163.11072